HomeBHC • NYSE
add
Bausch Health Companies Inc
Previous close
$6.13
Day range
$5.90 - $6.24
Year range
$4.25 - $8.69
Market cap
2.21B USD
Avg Volume
2.26M
P/E ratio
14.28
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.80B | 9.26% |
Operating expense | 1.28B | 3.40% |
Net income | -112.00M | -220.43% |
Net profit margin | -4.01 | -210.47% |
Earnings per share | 1.10 | -5.09% |
EBITDA | 1.01B | 11.84% |
Effective tax rate | 283.93% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.31B | 10.84% |
Total assets | 26.37B | -0.59% |
Total liabilities | 25.99B | -3.19% |
Total equity | 377.00M | — |
Shares outstanding | 370.56M | — |
Price to book | -4.09 | — |
Return on assets | 6.78% | — |
Return on capital | 8.41% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -112.00M | -220.43% |
Cash from operations | 495.00M | -17.64% |
Cash from investing | -282.00M | -41.00% |
Cash from financing | -235.00M | -376.47% |
Net change in cash | -15.00M | -103.33% |
Free cash flow | 206.50M | -43.35% |
About
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
CEO
Founded
1960
Headquarters
Website
Employees
20,300
